Current Strategies of Therapy in Alzheimer`s Disease

The molecular mechanisms involved in the plaques and tangles pathogenesis in Alzheimer`s disease (AD) discloses new potential targets for therapies that could modify the clinical course. In the last years, the neurotransmission defect (cholinergic hypothesis) has been extensively investigated. Choli...

Full description

Saved in:
Bibliographic Details
Published in:The open neuropsychopharmacology journal 2008-12, Vol.1 (1), p.19-23
Main Authors: Martocchia, A., Falaschi, P.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The molecular mechanisms involved in the plaques and tangles pathogenesis in Alzheimer`s disease (AD) discloses new potential targets for therapies that could modify the clinical course. In the last years, the neurotransmission defect (cholinergic hypothesis) has been extensively investigated. Cholinesterase inhibitors (donepezil, rivastigmine and galantamine) and N-methyl-D-aspartate receptor antagonist (memantine) are approved agents that can delay the cognitive deterioration. Recent evidence in the literature suggests innovative strategies of treatment in AD, acting at the level of the amyloid cascade that is related to the neuronal defects and the neurotransmission disturbances. Confirmatory data are necessary and they will arise from the clinical trials with these potential disease- modifying drugs.
ISSN:1876-5238
1876-5238
DOI:10.2174/1876523800801010019